Stay updated on Sparsentan in IgA Nephropathy: Clinical Trial

Sign up to get notified when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sparsentan in IgA Nephropathy: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    No significant changes were detected between the two screenshots; the page content and layout appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T12:49:06.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Added a site operation notice, introduced a new disease resource (IgA glomerulonephritis), and updated revision to v3.2.0 while removing v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T17:30:48.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-28T10:15:11.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:22:16.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-06T21:21:42.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional drug information for Sparsentan. Several previous locations and drug information have been removed.
    Difference
    17%
    Check dated 2025-08-30T15:48:40.000Z thumbnail image

Stay in the know with updates to Sparsentan in IgA Nephropathy: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.